Evidence map›Paper›PMID 24012566›Full record

ArticleVaccine2013

Immunisation with ID83 fusion protein induces antigen-specific cell mediated and humoral immune responses in cattle.

Gareth J Jones, Sabine Steinbach, Derek Clifford, Susan L Baldwin, Gregory C Ireton, Rhea N Coler, Steven G Reed, H Martin Vordermeier

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Gareth J JonesDepartment of Bovine TB, Animal Health and Veterinary Laboratories Agency, New Haw, Addlestone, Surrey KT15 3NB, United Kingdom. Electronic address: gareth.j.jones@ahvla.gsi.gov.uk.
Sabine Steinbach
Derek Clifford
Susan L Baldwin
Gregory C Ireton
Rhea N Coler
Steven G Reed
H Martin Vordermeier
Animal and Plant Health Agency · GBInfectious Disease Research Institute · US

Funding

Development and Manufacture of Adjuvants for Vaccines Targeting MDR TuberculosisU01AI078054 · NIAID · ACCESS TO ADVANCED HEALTH INSTITUTE · PI COLER, RHEA N · 2008 to 2011
$6.2M
HUMAN T CELLS ANTIGENS OF MYCOBACTERIUM TUBERCULOSISR01AI044373 · NIAID · INFECTIOUS DISEASE RESEARCH INSTITUTE · PI REED, STEVEN GREGORY · 1999 to 2009
$3.7M
NIAID NIH HHS AI-044373NIAID NIH HHS AI-078054NIAID NIH HHS HHSN272200800045CNIAID NIH HHS N01 AI025479NIAID NIH HHS R01 AI044373NIAID NIH HHS U01 AI078054
6 · The paper itself

Abstract

In this study we have investigated the potential of mycobacterial proteins as candidate subunit vaccines for bovine tuberculosis. In addition, we have explored the use of TLR-ligands as potential adjuvants in cattle. In vitro screening assays with whole blood from Mycobacterium bovis-infected and BCG-vaccinated cattle demonstrated that fusion protein constructs were most commonly recognised, and the ID83 fusion protein was selected for further immunisation studies. Furthermore, glucopyranosyl lipid A (GLA) and resiquimod (R848), agonists for TLR4 and TLR7/8 respectively, stimulated cytokine production (IL-12, TNF-α, MIP-1β and IL-10) in bovine dendritic cell cultures, and these were formulated as novel oil-in-water emulsions (GLA-SE and R848-SE) for immunisation studies. Immunisation with ID83 in a water-in-oil emulsion adjuvant (ISA70) induced both cell mediated and humoral immune responses, as characterised by antigen-specific IFN-γ production, cell proliferation, IgG1 and IgG2 antibody production. In comparison, ID83 immunisation with the novel adjuvants induced weaker (ID83/R848-SE) or no (ID83/GLA-SE) antigen-specific IFN-γ production and cell proliferation. However, both did induce ID83-specific antibody production, which was restricted to IgG1 antibody isotype. Overall, these results provide encouraging preliminary data for the further development of ID83 in vaccine strategies for bovine TB.

Indexed as

Immunity, CellularImmunity, HumoralAdjuvants, ImmunologicAnimalsAntibodies, BacterialAntigens, BacterialCattleCell ProliferationImidazolesImmunoglobulin GInterferon-gammaLeukocytes, MononuclearLipid AMycobacterium bovisRecombinant Fusion ProteinsTuberculosis, BovineAdjuvants, ImmunologicAntibodies, BacterialAntigens, BacterialImidazolesImmunoglobulin GInterferon-gammaLipid ARecombinant Fusion ProteinsresiquimodTuberculosis VaccinesVaccines, SubunitVaccines, SyntheticAdjuvantsBovine tuberculosisMycobacterium bovisVaccine

Identifiers

PMID24012566
PMCPMC3855245
OpenAlexW2012874024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.